Abstract 48: Factors Associated With Motor Performance in Patients With Mild Cognitive Impairment and Cerebral Small Vessel Disease: Data From the VMCI-Tuscany study
Background and purpose: Neuroimaging correlates of cerebral small vessel disease (SVD) are frequently detected in elderly subjects and are clinically associated with cognitive and gait dysfunction. Our aim was to evaluate clinical and neuroimaging factors associated with motor performance in a cohort of patients with mild cognitive impairment (MCI) and cerebral small vessel disease (SVD).
Methods: the VMCI Tuscany Study is an ongoing, longitudinal, multicenter, observational study aimed at investigating predictors of transition from vascular MCI to dementia. Inclusion criteria were: 1) MCI (Winblad et al. criteria), and 2) evidence on MRI of moderate to severe degrees of white matter hyperintensities [(WMH), modified Fazekas scale]. Centralized visual assessment also included: number of lacunar infarcts, microbleeds, cortical atrophy, and medial temporal lobe atrophy on MRI. All patients underwent clinical and functional evaluation. Quantitative tests of gait and balance included the Short Physical Performance Battery (SPPB; range: 0 [poor] to 12 [normal]).
Results: Out of the 145 patients enrolled (mean age 74.6±6.7, 55% males, 52% with severe WMH), mean SPPB score was 8.5±2.5, and Montreal Cognitive Assessment test (MoCA) 20.0±4.9. MoCA significantly correlated with SPPB (Spearman coefficient 0.204, p=0.014). The association also remained significant in the multivariate linear regression model (standardized coefficient 0.111, p=0.009), entering MoCA together with age, and neuroimaging variables. Among these latter, global atrophy retained a significant association (standardized coefficient -0.273, p=0.002).
Conclusion: in our cohort of MCI patients with moderate to severe WMH, motor performance was associated with cognitive performance. Among MRI features, cortical atrophy seem to have a primary role, in line with the recent view that regards cortical atrophy as one of the neuroimaging correlates of SVD.
Study funded by Tuscany Region.
Author Disclosures: A. Poggesi: None. E. Salvadori: None. G. Pracucci: None. R. Valenti: None. F. Pescini: None. M. Pasi: None. S. Nannucci: None. S. Marini: None. A. Del Bene: None. L. Ciolli: None. D. Inzitari: Research Grant; Modest; Bayer Italy, Shire Italy. Honoraria; Modest; Bayer Italy, Boeringher Italy. L. Pantoni: None.
- © 2015 by American Heart Association, Inc.